Koninklijke Dsm Nv Stock Fundamentals
Koninklijke DSM NV fundamentals help investors to digest information that contributes to Koninklijke DSM's financial success or failures. It also enables traders to predict the movement of Koninklijke OTC Stock. The fundamental analysis module provides a way to measure Koninklijke DSM's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Koninklijke DSM otc stock.
Koninklijke |
Koninklijke DSM NV OTC Stock Return On Equity Analysis
Koninklijke DSM's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Koninklijke DSM Return On Equity | 0.12 |
Most of Koninklijke DSM's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Koninklijke DSM NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Koninklijke DSM NV has a Return On Equity of 0.1189. This is 86.93% lower than that of the Basic Materials sector and 97.98% lower than that of the Specialty Chemicals industry. The return on equity for all United States stocks is 138.35% lower than that of the firm.
Koninklijke DSM NV Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Koninklijke DSM's current stock value. Our valuation model uses many indicators to compare Koninklijke DSM value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Koninklijke DSM competition to find correlations between indicators driving Koninklijke DSM's intrinsic value. More Info.Koninklijke DSM NV is currently regarded as top stock in return on equity category among related companies. It is currently regarded as top stock in return on asset category among related companies reporting about 0.34 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Koninklijke DSM NV is roughly 2.96 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Koninklijke DSM by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Koninklijke DSM's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Koninklijke DSM's earnings, one of the primary drivers of an investment's value.Koninklijke Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Koninklijke DSM's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Koninklijke DSM could also be used in its relative valuation, which is a method of valuing Koninklijke DSM by comparing valuation metrics of similar companies.Koninklijke DSM is currently under evaluation in return on equity category among related companies.
Koninklijke Fundamentals
| Return On Equity | 0.12 | |||
| Return On Asset | 0.0402 | |||
| Profit Margin | 0.11 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 24.43 B | |||
| Shares Outstanding | 691.88 M | |||
| Shares Owned By Institutions | 0.15 % | |||
| Price To Earning | 38.86 X | |||
| Price To Book | 2.36 X | |||
| Price To Sales | 2.39 X | |||
| Revenue | 9.2 B | |||
| Gross Profit | 3.16 B | |||
| EBITDA | 1.71 B | |||
| Net Income | 1.68 B | |||
| Cash And Equivalents | 1.63 B | |||
| Cash Per Share | 2.36 X | |||
| Total Debt | 2.84 B | |||
| Debt To Equity | 0.31 % | |||
| Current Ratio | 2.51 X | |||
| Book Value Per Share | 14.09 X | |||
| Cash Flow From Operations | 1.43 B | |||
| Earnings Per Share | 1.59 X | |||
| Price To Earnings To Growth | 2.81 X | |||
| Target Price | 44.0 | |||
| Number Of Employees | 21.76 K | |||
| Beta | 0.79 | |||
| Market Capitalization | 23.42 B | |||
| Total Asset | 16.01 B | |||
| Z Score | 4.2 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 1.95 % | |||
| Net Asset | 16.01 B | |||
| Last Dividend Paid | 2.63 |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in Koninklijke OTC Stock
If you are still planning to invest in Koninklijke DSM NV check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Koninklijke DSM's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stocks Directory Find actively traded stocks across global markets |